Workflow
四环生物(000518) - 2025 Q3 - 季度财报
JSSHJSSH(SZ:000518)2025-10-24 10:30

Financial Performance - The company's operating revenue for the third quarter reached ¥112,477,006.90, representing a 124.12% increase compared to the same period last year[5] - The net profit attributable to shareholders was -¥2,598,402.92, a decrease of 26.99% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was -¥2,772,112.03, reflecting a 57.29% increase in losses compared to the previous year[5] - The company's operating income for the year-to-date reached ¥294,374,160.07, an 88.71% increase compared to the same period last year[8] - Total operating revenue for Q3 2025 reached CNY 294,374,160.07, a significant increase from CNY 155,994,341.01 in the same period last year, representing an increase of 88.6%[15] - The net loss for Q3 2025 was CNY 13,495,557.26, compared to a net loss of CNY 15,532,421.60 in Q3 2024, showing an improvement of 13.2%[16] - Basic earnings per share (EPS) for the current period is -0.0123, compared to -0.0142 in the previous period[17] Cash Flow - The net cash flow from operating activities was ¥83,971,253.59, showing a significant increase of 11,516.57% year-on-year[5] - Cash flow from operating activities increased to 83,971,253.59 CNY from 722,857.64 CNY year-over-year, representing a significant improvement[18] - Cash inflow from operating activities totaled 254,497,038.80 CNY, up from 165,801,061.54 CNY in the previous period[17] - The net cash flow from financing activities was -¥14,197,661.13, a decrease of 117.55% compared to the previous year[8] - The net cash flow from financing activities was -14,197,661.13 CNY, worsening from -6,526,251.44 CNY year-over-year[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥509,144,403.06, down 10.27% from the end of the previous year[5] - The total assets decreased from CNY 567,402,831.84 in the previous quarter to CNY 509,144,403.06, a decline of 10.2%[15] - Total liabilities decreased from CNY 168,429,253.44 to CNY 123,666,381.92, representing a reduction of 26.6%[15] - The company's total equity decreased from CNY 398,973,578.40 to CNY 385,478,021.14, a decline of 3.8%[15] Inventory and Receivables - The company's inventory decreased by 38.24% to ¥222,259,127.65, attributed to increased sales of seedlings[8] - Inventory decreased to ¥222,259,127.65 from ¥359,876,908.61, reflecting a reduction of about 38.2%[13] - Accounts receivable rose to ¥74,290,478.79 from ¥66,065,029.10, indicating an increase of approximately 18.5%[13] - The total current assets decreased to ¥396,836,459.55 from ¥446,613,153.60, a decline of approximately 11.1%[13] Shareholder Information - The total number of common shareholders at the end of the reporting period is 68,146[9] - The largest shareholder, Fujian Bwater Agricultural Investment Co., Ltd., holds 27.78% of shares, totaling 285,990,000 shares[9] - The company has no preferred shareholders or significant changes in the top ten shareholders participating in margin trading[10] Strategic Initiatives - The company entered into a strategic cooperation agreement with Xinyang Xinport Trade Co., Ltd., establishing a long-term supply channel for seedlings, with a total contract value of ¥26,098,107[11] - The company plans to focus on expanding its market presence and enhancing product development in the upcoming quarters[16] Other Financial Metrics - The company's cash and cash equivalents increased to ¥85,982,480.18 from ¥8,012,633.33 at the beginning of the period, representing a significant growth[13] - The company reported a significant increase in other income, which rose by 5,252.25% to ¥742,914.83 due to government compensation for relocation[8] - Research and development expenses amounted to CNY 21,096,501.38, slightly up from CNY 20,697,253.25, reflecting a year-over-year increase of 1.9%[15] - The company reported an investment income of CNY 1,547,446.60, compared to no investment income in the previous year[16] Audit and Compliance - The company did not undergo an audit for the third quarter financial report[19] - The company has not applied the new accounting standards for the current reporting period[19] - There were no profits reported from the merged entity prior to the merger[17]